Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01157429 · ClinicalTrials.gov registry record · Phase 2
D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents
A Phase 2 study, sponsored by Tulane University School of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT01157429 is a Phase 2 study that has completed, run by Tulane University School of Medicine. The registered enrollment target is 24 participants.
The verdict
NCT01157429, a Phase 2 study, has completed, sponsored by Tulane University School of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to show whether D-cycloserine in combination with cognitive behavioral therapy (CBT) is more effective than CBT plus placebo to reduce symptoms of posttraumatic stress disorder (PTSD) in 13-18 year-old children.
Interventions
- DRUG Placebo pill
- BEHAVIORAL CBT
- DRUG D-cycloserine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2010-06 |
| Est. Completion | 2012-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01157429
The ClinicalTrials.gov registry entry for NCT01157429 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University School of Medicine, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo pill is the first listed.
NCT01157429 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01157429 about?
NCT01157429 is a clinical study titled "D-cycloserine Adjunctive Treatment for Posttraumatic Stress Disorder (PTSD) in Adolescents". The purpose of this study is to show whether D-cycloserine in combination with cognitive behavioral therapy (CBT) is more effective than CBT plus placebo to reduce symptoms of posttraumatic stress disorder (PTSD) in 13-18 year-old children.
What is the current status of trial NCT01157429?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2010-06. Estimated completion is 2012-06.
What interventions are being tested in trial NCT01157429?
The interventions under investigation include: Placebo pill (DRUG), CBT (BEHAVIORAL), D-cycloserine (DRUG).
Who is sponsoring clinical trial NCT01157429?
This trial is sponsored by Tulane University School of Medicine, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.